JPMorgan Chase & Co. 13D and 13G filings for Amicus Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-10-07 1:24 pm Sale |
2024-09-30 | 13G | Amicus Therapeutics, Inc. FOLD |
JPMORGAN CHASE & CO JPM |
12,823,682 4.300% |
-4,678,998 (-26.73%) |
Filing |
| 2024-01-08 09:09 am Purchase |
2023-12-29 | 13G | Amicus Therapeutics, Inc. FOLD |
JPMORGAN CHASE & CO JPM |
17,502,680 5.900% |
4,040,756 (+30.02%) |
Filing |
| 2023-01-05 11:11 am Sale |
2022-12-30 | 13G | Amicus Therapeutics, Inc. FOLD |
JPMORGAN CHASE & CO JPM |
13,461,924 4.700% |
-1,876,753 (-12.24%) |
Filing |
| 2022-01-19 12:37 pm Purchase |
2021-12-31 | 13G | Amicus Therapeutics, Inc. FOLD |
JPMORGAN CHASE & CO JPM |
15,338,677 5.500% |
15,338,677 (New Position) |
Filing |